Centre for Addiction and Mental Health, Temerty Centre for Therapeutic Brain Intervention, Toronto, Canada.
Department of Psychiatry, University of Toronto, Toronto, Canada.
Depress Anxiety. 2018 May;35(5):448-456. doi: 10.1002/da.22738. Epub 2018 Apr 10.
Dysfunctional neuroplasticity may be one of the pathophysiological mechanisms underlying major depression. We have previously established methods to assess neuroplasticity from the dorsolateral prefrontal cortex (DLPFC) using a paired associative stimulation (PAS) paradigm, which pairs a preceding peripheral nerve stimulation with subsequent transcranial magnetic stimulation (TMS) combined with electroencephalography (EEG). We aimed to investigate neuroplasticity through the PAS paradigm in the DLPFC in patients with depression compared to healthy subjects.
Twenty-nine patients with depression and 28 healthy controls participated in this study. There were no significant age or sex differences between the two groups. All participants received PAS paradigm in the DLPFC. We analyzed PAS induced potentiation from the DLPFC in both groups calculating the power of TMS-evoked potentials (TEP). A two-way ANOVA with PAS effect as a within-subject factor and diagnostic group as a between-subject factor was performed to examine the group differences in the PAS paradigm.
DLPFC-PAS induced a significant potentiation at the stimulation site in both patients and healthy subjects (mean ± SD: 1.24 ± 0.33 [μV] vs. 1.48 ± 0.28 [μV]). However, when we compared PAS potentiation between patients and healthy subjects, there were significant main effects of PAS (F = 68.63, p < 0.0001) and PAS-by-diagnostic group interaction (F = 25.05, p < 0.0001). Post hoc analysis demonstrated that patients had a significantly lower PAS potentiation compared to healthy subjects (t = 3.128, p = 0.003).
Our findings provide evidence for impaired neuroplasticity in DLPFC in patients with depression compared to healthy subjects. Such findings may ultimately help us understand the pathophysiology of MDD and mechanisms involved in its treatment.
神经功能失调可能是导致重度抑郁症的病理生理学机制之一。我们之前已经建立了使用成对关联刺激 (PAS) 范式评估背外侧前额叶皮层 (DLPFC) 神经可塑性的方法,该范式将先前的外周神经刺激与随后的经颅磁刺激 (TMS) 结合脑电图 (EEG) 结合使用。我们旨在通过与健康对照组相比,在抑郁症患者中研究 DLPFC 中的 PAS 范式下的神经可塑性。
29 名抑郁症患者和 28 名健康对照者参与了这项研究。两组之间在年龄和性别方面没有显着差异。所有参与者均在 DLPFC 中接受 PAS 范式。我们通过计算 TMS 诱发的脑电信号 (TEP) 的功率来分析两组的 DLPFC-PAS 诱导的增强。采用 PAS 效应作为内源性因素,诊断组作为组间因素的双因素方差分析来检验 PAS 范式中的组间差异。
在患者和健康受试者中,DLPFC-PAS 在刺激部位均引起明显的增强(平均值±标准差:1.24±0.33[μV]与 1.48±0.28[μV])。然而,当我们比较患者和健康受试者之间的 PAS 增强时,PAS 有显著的主效应(F=68.63,p<0.0001)和 PAS-诊断组的交互作用(F=25.05,p<0.0001)。事后分析表明,与健康受试者相比,患者的 PAS 增强明显降低(t=3.128,p=0.003)。
我们的研究结果提供了证据,表明与健康受试者相比,抑郁症患者的 DLPFC 神经可塑性受损。这些发现最终可能有助于我们了解 MDD 的病理生理学和其治疗的相关机制。